ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,827.20
      0.94%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,323.22
      -0.58%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PhaseBio Pharmaceuticals Inc (PHAS)

      7. PhaseBio Pharmaceuticals Inc (PHAS) News

      PHAS

      PhaseBio Pharmaceuticals (PHAS)

      PhaseBio Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PHAS
      DateTimeSourceHeadlineSymbolCompany
      04/05/20194:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      04/04/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/26/20194:47PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/26/20194:12PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/26/20194:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/26/20194:01PMGlobeNewswire Inc.PhaseBio Reports Fourth Quarter and Full-Year 2018 Financial and Business ResultsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/25/20194:30PMGlobeNewswire Inc.PhaseBio Announces Term Loan of up to $15 MillionNASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/21/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/19/20198:00AMGlobeNewswire Inc.PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/17/20193:00PMGlobeNewswire Inc.Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at...NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/06/20198:00AMGlobeNewswire Inc.PhaseBio to Present at Cowen and Company 39th Annual Health Care ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/04/20198:30AMGlobeNewswire Inc.PhaseBio Appoints Richard A. van den Broek to Board of DirectorsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/04/20198:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/04/20198:00AMGlobeNewswire Inc.PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Present...NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:14PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20195:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      03/01/20194:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
      02/12/201910:03AMEdgar (US Regulatory)Schedule 13gNASDAQ:PHASPhaseBio Pharmaceuticals Inc
      01/25/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:PHAS

      Your Recent History

      BIT
      P80887
      BNP Paribas
      Delayed Upgrade Clock